In PACG: (↑) osteopontin (OPN), Cystatin C; (↓) cathepsin D. Elevated levels of OPN and cystatin C in PACG along with altered cathepsin levels may contribute to ECM aberration in glaucoma. The gene discussed is CST3; the disease is glaucoma.